Omega Healthcare Investors, Inc. (OHI) — Financial statements
Income statement, balance sheet, and cash flow for Omega Healthcare Investors, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,198↑14.0% | 1,051↑10.7% | 950↑8.1% | 878↓17.4% | 1,063 | |
| Cost of Revenue | 665↑4466.5% | 15↓3.1% | 15↓3.1% | 16↑26.4% | 12 | |
| Gross Profit | 533↓48.6% | 1,037↑10.9% | 935↑8.3% | 863↓17.9% | 1,051 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 88↑8.0% | 82↑17.4% | 69↑7.4% | 65 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↓100.0% | 88↑8.0% | 82↑17.4% | 69↑7.4% | 65 | |
| Other Expenses | -216↓174.8% | 289↓20.6% | 364↓9.2% | 401↓4.4% | 420 | |
| Operating Expenses | -216↓157.3% | 377↓15.4% | 446↓5.3% | 470↓2.9% | 484 | |
| Total Costs & Expenses | 449↑14.5% | 392↓15.0% | 461↓5.2% | 486↓2.1% | 497 | |
| Operating Results | ||||||
| Operating Income | 749↑13.6% | 660↑34.9% | 489↑24.6% | 392↓30.7% | 566 | |
| Depreciation & Amortization | 325↑6.8% | 305↓4.7% | 320↓3.8% | 332↓2.8% | 342 | |
| EBITDA | 1,170↑23.5% | 947↑16.8% | 811↓19.1% | 1,002↑0.9% | 993 | |
| EBIT | 845↑31.5% | 642↑30.8% | 491↓26.6% | 669↑2.9% | 651 | |
| Interest & Other Income | ||||||
| Net Interest Income | -45↑79.5% | -222↑5.9% | -236↓1.0% | -233↑0.6% | -235 | |
| Interest Income | 175 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 221↓0.5% | 222↓5.9% | 236↑1.0% | 233↓0.6% | 235 | |
| Non-Operating Income | -95↓654.1% | 17↑885.8% | -2↑99.2% | -277↓227.9% | -85 | |
| Other Income / Expenses | -125↑45.8% | -231↑1.2% | -234↓557.5% | 51↑138.1% | -134 | |
| Income Before Tax | 624↑45.6% | 429↑68.1% | 255↓42.5% | 443↑2.6% | 432 | |
| Income Tax Expense | 15↑35.8% | 11↑73.6% | 6↑37.1% | 5↑18.8% | 4 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 609↑45.9% | 418↑67.9% | 249↓43.3% | 439↑2.5% | 428 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 590↑45.2% | 406↑67.8% | 242↓43.3% | 427↑2.4% | 417 | |
| Bottom-Line Net Income | 590↑41.0% | 418↑67.9% | 249↓43.2% | 439↑2.5% | 428 | |
| EPS (Basic) | 2.02↑28.7% | 1.57↑55.4% | 1.01↓44.2% | 1.81↑2.8% | 1.76 | |
| EPS (Diluted) | 1.94↑25.2% | 1.55↑55.0% | 1.00↓44.4% | 1.80↑2.9% | 1.75 | |
| Weighted Average Shares | 296↑14.7% | 258↑7.3% | 240↑1.8% | 236↓0.3% | 237 | |
| Weighted Average Diluted Shares | 311↑14.9% | 270↑8.0% | 250↑2.5% | 244↓0.0% | 244 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.